The Law Offices of Todd M. Garber announces that shareholders of LHC
Group, Inc. (“LHC” or the “Company”) (NASDAQ:LHCG) have until August 13,
2012 to move for lead plaintiff status in the shareholder lawsuit filed
in the United States District Court for the Western District of
Louisiana. The lawsuit was filed on behalf of a class (the “Class”)
comprising all persons or entities who purchased or otherwise acquired
LHC common stock between July 30, 2008 and October 26, 2011, inclusive
(the “Class Period”).
LHC, together with its subsidiaries, provides post-acute health care
services throughout the United States, primarily to Medicare
beneficiaries. The Complaint alleges that the defendants issued
materially false and misleading statements concerning LHC’s business and
financial prospects, in violation of federal securities laws.
Specifically, the Complaint alleges that during the Class Period the
Company and its chief executive officer failed to disclose that the
reported growth in LHC’s home-based healthcare segment was primarily
created by the Company maximizing its Medicare reimbursement by
manipulating the number of patient visits, regardless of patient need,
to achieve the most profitable number of therapy visits under the
Medicare home health program.
If you purchased LHC common stock between July 30, 2008 and October 26,
2011, you may move the Court no later than August 13, 2012 to serve as
lead plaintiff; however, you must meet certain legal requirements. To be
a member of the Class you need not take any action at this time. You may
retain counsel of your choice or take not action and remain an absent
Class member. If you wish to discuss this action or have any questions
concerning this Notice or your rights or interests with respect to these
matters, please contact Todd M. Garber, Esquire, of the Law Offices of
Todd M. Garber, by telephone at 213-700-7262 or by email to firstname.lastname@example.org.
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.